About JNPMEDI
JNPMEDI is a company based in Incheon (South Korea) founded in 2020. JNPMEDI has raised $10.3 million across 1 funding round from investors including Aju IB Investment, Kakao Ventures and Gentium Partners. JNPMEDI offers products and services including Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services. JNPMEDI operates in a competitive market with competitors including Lokavant, eClinical Solutions, Datacubed, SolveBio and IgniteData, among others.
- Headquarter Incheon, South Korea
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Jnpmedi Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.3 M (USD)
in 1 rounds
-
Latest Funding Round
$10.3 M (USD), Series A
Nov 21, 2022
-
Investors
Aju IB Investment
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of JNPMEDI
JNPMEDI offers a comprehensive portfolio of products and services, including Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services.
End-to-end solution for clinical trial operations and data management.
Tool for collecting and managing clinical trial data efficiently.
Platform for electronic clinical outcome assessments in trials.
On-demand support for life science business strategies and development.
People of JNPMEDI
Unlock access to complete
Unlock access to complete
Funding Insights of JNPMEDI
JNPMEDI has successfully raised a total of $10.3M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.3 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in JNPMEDI
JNPMEDI has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Aju IB Investment, Kakao Ventures and Gentium Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are directed toward IT startups.
|
Locked | Locked | Locked | |
|
Diversified investment, VC & financial advisory firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for JNPMEDI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by JNPMEDI
Investment portfolio details for JNPMEDI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - JNPMEDI
Detailed financials for JNPMEDI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jnpmedi Comparisons
Peer comparison for JNPMEDI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of JNPMEDI
JNPMEDI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lokavant, eClinical Solutions, Datacubed, SolveBio and IgniteData, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of clinical data analytics and trial management platform for CRO
|
|
| Locked | Locked | Locked |
Cloud-based software solutions for clinical data management are provided.
|
|
| Locked | Locked | Locked |
Provider of solutions for patient engagement and data management in clinical trails
|
|
| Locked | Locked | Locked |
Genomic data analytics platform is provided for precision medicine.
|
|
| Locked | Locked | Locked |
Patient data is transformed for clinical trials via archer technology.
|
Detailed competitors of JNPMEDI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jnpmedi
Complete news archive for JNPMEDI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JNPMEDI
JNPMEDI was founded in 2020 and raised its 1st funding round 2 years after it was founded.
JNPMEDI is headquartered in Incheon, South Korea.
Kwunho Jeong is the current CEO of JNPMEDI.
JNPMEDI is a funded company, having raised a total of $10.3M across 1 funding round to date.
JNPMEDI was founded in 2020 in Incheon, South Korea, as a provider of cloud-based clinical trial data management solutions. A SaaS platform is utilized to deliver digitalization services across pharmaceuticals, biotechnology, digital medicines, and digital medical devices. Operations focus on streamlining data handling for these sectors, with services tailored to support research and development processes in the healthcare industry.
JNPMEDI's top competitors include Lokavant, eClinical Solutions and IgniteData.
JNPMEDI offers Maven Clinical Cloud, Maven CDMS, Maven eCOA, and Professional Services.
JNPMEDI has 5 investors. Key investors include Aju IB Investment, Kakao Ventures, Gentium Partners, Pavilion Capital Partners, and Murex Partners.